Dossa Fahima, Sutradhar Rinku, Saskin Refik, Hsieh Eugene, Henry Pauline, Richardson Devon P, Leake Pierre-Anthony, Forbes Shawn S, Paszat Lawrence F, Rabeneck Linda, Baxter Nancy N
Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Colorectal Dis. 2021 Mar;23(3):635-645. doi: 10.1111/codi.15400. Epub 2020 Nov 17.
Factors associated with verified post-colonoscopy colorectal cancers (PCCRC) have not been well defined and survival for these patients is not well described. We aimed to assess the association of patient, tumour and endoscopist characteristics with PCCRC.
Using population-based data, we identified individuals diagnosed with CRC from 1 January 2000 to 31 December 2005 who underwent a colonoscopy within 3 years prior to diagnosis. Detected cancers were those diagnosed ≤6 months following colonoscopy; PCCRC were diagnosed >6 months to ≤3 years following colonoscopy. Post-colonoscopy and detected cancers were verified through chart review using a hospital-based simple random sampling frame. We used multivariable conditional logistic regression to determine the association of patient, tumour and endoscopist factors with PCCRC and compared overall survival using Cox proportional hazard models.
Using the random sampling frame, we identified 498 patients with PCCRC and 498 with detected CRC; we obtained records and confirmed 367 patients with PCCRC and 412 with detected cancers. In multivariable analysis, patient age (OR 1.01; 95% CI 1.00-1.03) and tumour location (distal vs. proximal OR 0.36; 95% CI 0.25-0.53) were associated with PCCRC; endoscopist quality measures were not significantly associated with PCCRC. We did not find significant differences in overall survival between PCCRC and detected cancers (hazard ratio 1.12; 95% CI 0.92-1.32).
Although endoscopic quality measures are important for CRC prevention, endoscopist factors were not associated with PCCRC. This study highlights the need for further research into the role of tumour biology in PCCRC development.
经结肠镜检查确诊的结直肠癌(PCCRC)相关因素尚未明确界定,这些患者的生存情况也未得到充分描述。我们旨在评估患者、肿瘤及内镜医师特征与PCCRC之间的关联。
利用基于人群的数据,我们确定了2000年1月1日至2005年12月31日期间被诊断为结直肠癌且在诊断前3年内接受过结肠镜检查的个体。检测到的癌症是指在结肠镜检查后≤6个月内诊断出的癌症;PCCRC是指在结肠镜检查后>6个月至≤3年内诊断出的癌症。通过使用基于医院的简单随机抽样框架进行病历审查来核实结肠镜检查后及检测到的癌症。我们使用多变量条件逻辑回归来确定患者、肿瘤及内镜医师因素与PCCRC之间的关联,并使用Cox比例风险模型比较总生存率。
使用随机抽样框架,我们确定了498例PCCRC患者和498例检测到的结直肠癌患者;我们获取了记录并确认了367例PCCRC患者和412例检测到癌症的患者。在多变量分析中,患者年龄(比值比1.01;95%置信区间1.00 - 1.03)和肿瘤位置(远端与近端比值比0.36;95%置信区间0.25 - 0.53)与PCCRC相关;内镜医师质量指标与PCCRC无显著关联。我们未发现PCCRC与检测到的癌症之间在总生存率上有显著差异(风险比1.12;95%置信区间0.92 - 1.32)。
尽管内镜质量指标对结直肠癌预防很重要,但内镜医师因素与PCCRC无关。本研究强调需要进一步研究肿瘤生物学在PCCRC发生中的作用。